Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dysthyroid Ophthalmopathies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT02339142
What this trial is testing

Combined Radiotherapy and Intravenous Steroids for Early Progressive Thyroid Eye Disease

Who this might be right for
Graves Ophthalmopathy
University of British Columbia 100
Not applicableUnknownNCT04359979
What this trial is testing

Tamsulosin for Thyroid Lid Retraction

Who this might be right for
Thyroid Eye DiseaseEyelid Diseases
Sheba Medical Center 50
Not applicableUnknownNCT00174057
What this trial is testing

The Role of TSH Receptor, PPAR-r, IGF-1R, IGF and Cytokines in Different Stages of Graves'Ophthalmopathy

Who this might be right for
Graves' Ophthalmopathy
National Taiwan University Hospital 50
Testing effectiveness (Phase 2)Study completedNCT06226545
What this trial is testing

Evaluate the Efficacy and Safety of LASN01 in Patients With Thyroid Eye Disease

Who this might be right for
Thyroid Eye DiseaseGraves OphthalmopathyGraves Orbitopathy+5 more
Lassen Therapeutics Inc. 41
Large-scale testing (Phase 3)Not Yet RecruitingNCT07720648
What this trial is testing

A Phase III Study of KHN939 in Chinese Patients With Moderate-to-Severe Inactive Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease
Beijing Kanghong Biological Medicine Co., Ltd. 117
Not applicableStudy completedNCT05793359
What this trial is testing

Comparison of the Effectiveness of Two Glucocorticoid Regimens for Treatment of Graves' Orbitopathy

Who this might be right for
Graves Ophthalmopathy
Medical University of Sofia 62
Early research (Phase 1)Study completedNCT06563856
What this trial is testing

TEPEZZA Subcutaneous Administration in Healthy Adults

Who this might be right for
BioavailabilityBioequivalence
Amgen 37
Not applicableUnknownNCT03324022
What this trial is testing

Observing the Relationship of Fibroblast Growth Factor and Fibroblast in Thyroid Eye Disease

Who this might be right for
Graves Ophthalmopathy
National Taiwan University Hospital 80
Testing effectiveness (Phase 2)Ended earlyNCT00288522
What this trial is testing

Lanreotide (Somatuline Autogel) in Thyroid-associated Ophthalmopathy Treatment

Who this might be right for
Thyroid-Associated Ophthalmopathy
Ipsen 5
Not applicableActive Not RecruitingNCT07472062
What this trial is testing

Development of a Non-Invasive Prognostic Test for Graves Orbitopathy

Who this might be right for
Graves OrbitopathyHyperthyroidism
University Hospital, Ghent 90
Not applicableUnknownNCT05199103
What this trial is testing

Antithymocyte Globulin as a Second Line Therapy in Graves Orbitopathy

Who this might be right for
Graves Orbitopathy
Medical University of Silesia 20
Not applicableStudy completedNCT00004660
What this trial is testing

Randomized Study of Sequential Orbital Radiotherapy for Graves' Ophthalmopathy

Who this might be right for
Graves' Disease
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 42
Not applicableStudy completedNCT04025034
What this trial is testing

Deep Lateral Wall Partial Rim-Sparing Orbital Decompression for Treatment of Thyroid-Related Orbitopathy

Who this might be right for
ExophthalmosOrbitopathy, GravesSurgery
Hospital Universitario 12 de Octubre 35
Large-scale testing (Phase 3)Study completedNCT01579539
What this trial is testing

The Effect of Intravenous Glucocorticoids on the Tearfilm in Eyes With Thyroid-associated Ophthalmopathy

Who this might be right for
Thyroid-associated OphthalmopathyDry Eye Syndrome
Medical University of Vienna 18
Post-approval studies (Phase 4)Study completedNCT02378298
What this trial is testing

Rituximab (RTX) Therapy in Patients With Active TAO

Who this might be right for
Ophthalmopathy, Thyroid-Associated
Göteborg University 38
Early research (Phase 1)Not Yet RecruitingNCT07762105
What this trial is testing

Study of Atorvastatin and Its Effects in Clinical and Radiological Aspects in Patients With Moderate-to-Severe Thyroid Eye Disease

Who this might be right for
Thyroid Eye DiseaseGraves OphthalmopathyGraves Orbitopathy
Banu Aji Dibyasakti 64
Not applicableStudy completedNCT03195296
What this trial is testing

T and B Cells in Graves' Orbitopathy

Who this might be right for
Graves Ophthalmopathy
University of Pisa 20
Not applicableStudy completedNCT06367517
What this trial is testing

Tocilizumab in Corticosteroid-Resistant Graves' Orbitopathy (Thyroid Eye Disease)

Who this might be right for
Orbitopathy, GravesThyroid Eye DiseaseOphthalmopathy
Medical University of Warsaw 32
Not applicableLooking for participantsNCT06590220
What this trial is testing

Establishment of Multiparametric Prediction Models for Moderate to SevereThyroid Associated Ophthalmopathy

Who this might be right for
Thyroid Associated Ophthalmopathy
Shanghai Changzheng Hospital 150
Not applicableStudy completedNCT07444190
What this trial is testing

Psychological Burden of Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease, TED
Thomas Jefferson University 20
Next Page